Great documentation
Support answered a batch question within a few hours over email. Rare to get that level of response from a research supplier. Product itself is exactly to spec.

40 mg · ≥99% purity
Pre-filled research auto-injector pen — 40mg.
£199.00 per pen · Tax calculated at checkout · Free tracked UK & EU shipping over £50

Every batch is independently HPLC assayed. Certificate of Analysis available on request.
Every UK order includes — free
Full refund
if a batch is off-spec
Free reship
if lost or damaged in transit
Same-day dispatch
Mon–Fri, order before 12:00 UK
Research use only
for laboratory work
Analytical data
Identity data cross-checked against PubChem; purity taken from the batch certificate of analysis.
About this compound
Triple GIP / GLP-1 / glucagon analogue
Half-life
≈ 6 days
First disclosed
2022
Retatrutide (LY3437943) is an investigational tri-agonist peptide activating the GIP, GLP-1 and glucagon receptors. Published data place it among the most potent incretin compounds reported in laboratory metabolic-pathway research.
Balanced triple-receptor agonism is studied in vitro for combined incretin- and glucagon-receptor signalling.
Research areas
Research literature
Browse this research area
Reta Pen is a pre-filled research auto-injector pen supplied for in vitro laboratory use, supplied by MyPeptides for laboratory research use only.
The Reta Pen holds 40 mg of retatrutide (LY3437943), the investigational tri-agonist peptide that activates the GIP, GLP-1 and glucagon receptors, in a pre-filled, ready-assembled research pen.
Retatrutide is studied in laboratory metabolic-pathway research as one of the most potent incretin compounds reported, and is often compared with the dual agonist tirzepatide and the GLP-1 / glucagon agonist mazdutide. The same compound is also available as 5 mg and 10 mg lyophilised vials.
Dispatched the same working day when ordered before 12:00 UK time, tracked and free over £50. Store refrigerated at 2–8 °C, protected from light. For laboratory research use only.
Straight answers on purity, handling, dispatch and research use.
Reta Pen is a pre-filled research auto-injector pen supplied for in vitro laboratory use, supplied by MyPeptides as a pre-filled research pen for laboratory research use only.
In cited literature, Reta Pen is studied in metabolic and receptor-signalling research programmes. It is not a medicine and is not intended for human or veterinary use.
Every batch is third-party HPLC assayed at ≥99% purity. A signed certificate of analysis is available on request after checkout.
Store refrigerated at 2–8 °C, protected from light. Do not freeze once assembled. Follow your lab's SOP for handling research auto-injectors.
Yes — tracked Royal Mail and DPD dispatch across the UK and EU, with free shipping on orders over £50. Weekday orders placed before 12:00 UK time ship the same day.
Verified feedback from qualified researchers across the UK & EU.
Support answered a batch question within a few hours over email. Rare to get that level of response from a research supplier. Product itself is exactly to spec.
Documentation is what sold me. Independent CoA per batch, clean HPLC traces. Reconstitution behaved exactly as expected. Solid supplier for research use.
Ordered late Monday, arrived Wednesday morning in the UK. Packaging was cold-protected and every vial sealed correctly. CoA matched the batch number on the label.
Everything about this feels professional - from the site to the packaging to the paperwork. Purity assay matches what is on the label. Will keep ordering.
Ordered a bundle to save on shipping - all vials arrived in one insulated pack, labels identical batch, CoA covers the lot. Great value.
Clean product, no discoloration, correct fill. Certificate of analysis was in the box AND emailed. Very straightforward experience.
More pens from the mypeptides research catalog.